Skip to main content

Table 2 Secondary outcomes

From: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study

 

D0 (n)

M3 (n)

M6 (n)

Haematocrit (%)

29.54 ± 4.12 (2158)

34.41 ± 5.78 (1839)

34.90 ± 6.03 (1419)

Reticulocytes (/mm3)

53083.10 ± 43772.32 (330)

57478.34 ± 47391.55 (228)

52803.71 ± 52301.40 (146)

Iron (μg/100 mL)

94.96 ± 129.22 (546)

140.39 ± 152.77 (295)

144.98 ± 152.96 (182)

Ferritin (ng/mL)

510.55 ± 629.61 (555)

512.83 ± 801.58 (301)

390.82 ± 466.91 (214)

sBP (mmHg)

125.75 ± 14.48 (1934)

125.58 ± 15.80 (1675)

126.04 ± 15.41 (1353)

dBP (mmHg)

74.18 ± 9.79 (1930)

74.51 ± 10.31 (1675)

74.33 ± 10.02 (1351)

  1. dBP, diastolic blood pressure; sBP, systolic blood pressure.